Stevens-Johnson syndrome after amifostine during radiotherapy.
Astudillo
Leonardo
L
Department of Internal Medicine, University Hospital Purpan, Toulouse cedex, France, the Burn Center, University Hospital, Bordeaux cedex, France. astudillo.l@chu-toulouse.fr
Maachi
Boujemaa
B
Benyoucef
Ahmed
A
Game
Xavier
X
Rives
Michel
M
Bachaud
Jean-Marc
JM
D004999:Amifostine / Q000008:administration & dosage / Q000009:adverse effects*; D002277:Carcinoma / Q000532:radiotherapy; D006801:Humans; D007275:Injections, Intravenous; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D011837:Radiation-Protective Agents / Q000008:administration & dosage / Q000009:adverse effects*; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced*; D014062:Tongue Neoplasms / Q000532:radiotherapy; D014987:Xerostomia / Q000517:prevention & control
D011837:Radiation-Protective Agents; D004999:Amifostine